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Abstract 
Osteoporotic vertebral fractures represent major cause of disability, loss of quality of life and even 
mortality among the elderly population. Decisions on drug therapy are based on the assessment of 
risk factors for fracture, from bone mineral density measurements. The combination of bio- 
mechanical models with clinical studies could better estimate bone strength and support the spe-
cialists in their decision. A model to assess the probability of fracture, based on the Damage and 
Fracture Mechanics has been developed, evaluating the mechanical magnitudes involved in the 
fracture process from clinical bone mineral density measurements. The model is intended for si-
mulating the degenerative process in the skeleton, with the consequent lost of bone mass and 
hence the decrease of its mechanical resistance which enables the fracture due to different trau-
matisms. Clinical studies were chosen, both in non-treatment conditions and receiving drug 
therapy, and fitted to specific patients according their actual bone mineral density measures. The 
predictive model is applied in a finite element simulation of the lumbar spine. The fracture zone 
would be determined according loading scenario (fall, impact, accidental loads, etc.), using the 
mechanical properties of bone obtained from the evolutionary model corresponding to the consi-
dered time. Bone mineral density evolution in untreated patients and in those under different 
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treatments was analyzed. Evolutionary curves of fracture probability were obtained from the 
evolution of mechanical damage. The evolutionary curve of the untreated group of patients 
presented a marked increase of the fracture probability, while the curves of patients under drug 
treatment showed variable decreased risks, depending on the therapy type. The finite element 
model allowed obtaining detailed maps of damage and fracture probability, identifying high-risk 
local zones at vertebral body, which are the usual localization of osteoporotic vertebral fractures. 
The developed model is suitable for being used in individualized cases. The model might better 
identify at-risk individuals in early stages of osteoporosis and might be helpful for treatment 
decisions. 
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1. Background 
Currently, osteoporotic fractures represent major cause of disability, loss of quality of life and even death among 
the elderly population [1]. Osteoporosis is caused by a skeletal involution linked to aging, which is more preva-
lent in women: the lifetime risk for a fragility fracture at the age of 50 lies within the range of 40% in women [2]. 
Vertebral fracture is the most common osteoporotic fracture, being more prevalent in women than in men [3] 
[4], leading to back pain, kyphosis and severe functional and vital impact in 30% - 50% of patients [5] [6]. 
Underdiagnosis of osteoporotic vertebral fracture is common for the lack of complementary tests in older 
women who visit the doctor complaining of back pain and sometimes because the symptomatology of the first 
fracture is not evident [7] [8]. 
Different publications estimate that only 40% of fractures are diagnosed [8] [9]; other assessments estimate 
that only 5% - 20% of these vertebral fractures are diagnosed in primary care [10]. The first vertebral fracture is 
a factor of high risk of new fractures, localized in another vertebra or other areas of skeleton [11]-[15], leading 
to so-called fracture cascade [16], when new fractures occur in the spine.  
Decisions on drug therapy in osteoporotic patients without previous fractures are mainly based on the analysis 
of risk factors which predispose to fracture. A risk assessment tool called FRAX® (Fracture Risk Assessment 
Tool) has been developed by the World Health Organization (WHO) for this purpose [17]-[20]. The risk of ma-
jor osteoporotic fractures (hip, vertebrae, humerus and wrist), or specifically hip fracture over the next 10 years 
can be estimated with the FRAX® tool. The probability of fracture is calculated on the basis of age, body mass 
index and several dichotomized variables (previous fracture, smoking, rheumatoid arthritis, etc.). Optionally, 
Bone Mineral Density (BMD) of the femoral neck can be included for risk calculation. Other studies have ques-
tioned the effectiveness of FRAX® as a tool for predicting fracture risk [21] [22]. 
Several previous surveys have assessed the risk of fracture using various methodologies mostly based on 
BMD measurements [23] [24]. BMD measurements have also been used for determining the mechanical 
strength [25] or to develop statistical models for predicting the risk of fracture [26]. Another study used mor-
phological measurements of the femoral head and neck to determine the risk of fracture [27]. 
In the field of Finite Element (FE) simulation, different models were used for predicting bone strength or 
fracture risk at different ages. So, Lee [28] presents a micromechanical model of bone behavior, which is diffi-
cult to extrapolate to the scale required to get realistic predictions. Boccacio, Zhang [29] [30] develop more ad-
vanced macro-mechanical models, analyzing a complete functional unit of the spine in terms of mechanical be-
havior depending on bone density. MacNeil [31] builds a 2D model in the sagittal plane, using bone geometry 
and BMD measurements obtained from radiographs and Dual-energy X-ray Absorptiometry (DXA), calculating 
the stiffness in terms of patient’s age. For proximal femoral fractures, Kaneko [32] develops a model based on 
imaging techniques, establishing a statistical correlation between the prediction of bone strength and the risk of 
osteoporotic fracture. A different methodology is applied by Bryan [33], who suggests a parametric model in-
corporating both the geometry and the properties of bone. A similar methodology is used by Bessho [34], with a 
parametric analysis concerning load and support conditions. Some authors have begun to incorporate yield crite-
E. López et al. 
 
 529 
ria for fracture risk prediction, as Derikx [35], who applies the Drucker-Prager criterion on a model made from 
Quantitative Computed Tomography (QCT), with asymmetric yielding in tension and compression. In a similar 
way, Tellache [36] applies an anisotropic yield criterion on a model constructed from Computed Tomography 
(CT) for predicting fracture risk. With a different approach, Amin [37] performs a comparative analysis of frac-
ture risk predictions based on BMD measurements against those ones obtained from an FE model developed 
from QCT. Finally, on the matter of drug treatments, Keaveny [38] analyzes the influence on bone strength of 
Parathyroid Hormone (PTH) and alendronate, using a FE model developed from QCT scans of osteoporotic pa-
tients.  
Currently, the most popular clinical tool for fracture risk assessment is FRAX®, which doesn’t consider bone 
strength as a relevant magnitude. All the aforementioned computational methods use clinical or mechanical 
magnitudes related to bone fracture in an independent way, without considering their mutual influence as it ac-
tually happens.  
In view of the current models limitations, we have developed a model for predicting the risk of osteoporotic 
vertebral fractures based on the Damage Mechanics and Fracture Mechanics. The model is incorporated into a 
finite element code to simulate the damage evolution over time. Thus, we will estimate the probability of verte-
bral fracture in the mid and long terms. BMD measurements, from DXA scans, will be incorporated into the 
model in order to fit it to clinical conditions. The model is not intended for simulating the bone fracture, but to 
predict the degenerative process in the skeleton, with the consequent lost of bone mass and hence the decrease of 
its mechanical resistance which enables the fracture due to different traumatisms. 
2. Methods 
In order to develop a predictive model which takes into account the mechanical parameters involved in the frac-
ture process, a correlation between these magnitudes and those ones measured in clinical terms is firstly required. 
To this effect, Carter and Hayes [39] established a direct relationship between Young’s modulus, E, and bone 
apparent density, ρ, for low strain rates (0.01): 
32875E ρ=                                      (1) 
On the other hand, the relationship between the BMD value and the apparent density is adjusted, according to 
experimental results, as:  
max
max
BMD
BMD
λ
ρ ρ
 
=  
 
                                 (2) 
being λ a numerical parameter that depends on the sample data. For the present study a value of 0.36 was as-
signed for λ in order to fit the actual data presented in [40].  
BMD is the current standard for diagnosis of osteoporosis. Over 100 worldwide published papers assessing 
lumbar spine BMD evolution, both in natural conditions and in patients under drug therapy were selected for 
analysis. Among them, two treatments have been selected for the comparative study: risedronate, a biphospho-
nate, in dosage of 5 mg per day [41] and denosumab, a human monoclonal antibody, in dosage of 60 mg per 6 
months [42]. These drugs have proven to be effective, and their BMD evolution curves show the required regu-
larity in the analyzed time period.  
Bisphosphonates settle in the bone tissue and its effect persists during some time after its administration, and 
hence it is completely accepted in the clinical practice the use of intermittent or discontinuous treatments. For 
the risedronate, several studies with a dosage of 5 mg/day [43] [44] corroborate its effectiveness, decreasing the 
risk of vertebral fractures in women with osteoporosis, improving even in week dosage the results obtained with 
alendronate [45].  
With respect to the use of denosumab, its action principle deals with the blocking of natural bone resorption. 
Its effectiveness reducing the fracture risk has been demonstrated in a 5 years study [46], being recommendable 
its use in women with a high fracture risk. 
Regarding the natural history of BMD, the average curve published by Mazess [47] was chosen as a reference. 
Briefly, the natural curve of BMD linked with age was compared to the curves of BMD in patients treated with 
bisphosphonates or denosumab. 
As the model evaluates the mechanical strength of bone from BMD, an analytical function expressing its 
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evolution over time is needed. That function must be obtained from numerical data contained in different studies. 
Since the standard adjustment techniques do not provide enough accuracy and reliability to be applied to the 
predictive model, more complex adjustments have been set out to obtain continuous curves of regression. These 
make it possible to obtain continuous curves for the BMD evolution. The evolution trends of the different se-
lected cases in the study can be extrapolated from those continuous curves, ensuring a consistent behavior. The 
following adjustments were proposed for the apparent density ρ: 
• Polynomial: 
1
1 1 0
n n
n na t a t a t aρ
−
−= + + + +                              (3) 
• Exponential: 
( )11 1 01
n n
n na t a t a t ak eρ
−
−− + + + + = − 
 

                             (4) 
• Exponential asymptotic: 
( )0 0 1 m
at
t t
l m eρ ρ ρ ρ
−
−
 
 = + − −
 
 
í                              (5) 
These adjustments (Equations (3), (4) and (5)) have been applied to the three examined curves (natural evolu-
tion and the two therapies). Several choices have been made during this adjustment: the lowest mean square er-
ror, the closest to unity correlation coefficient R2, and a 10-year standardized follow-up period with the possibil-
ity of extrapolation to longer periods up to 15 years (Figure 1). That extrapolation is intended to be consistent in 
mathematical terms, independently of the actual duration of the considered study. This condition will permit in 
the future an easy incorporation of more long term studies when available. Standardization of BMD measure-
ments included in each published paper was required in order to make comparisons among them [48], because 
de data were obtained from different densitometric equipment depending on the study (Hologic, Lunar and Nor-
land). 
The Karganovin’s Damage Mechanics model [49] was selected for the simulation of the degenerative process. 
This model defines the mechanical damage, D, as a function of the equivalent strain, cε : 
( )1 cD
γκ ε= −                                   (6) 
being: 
2 2 2
c I II III I II I III II IIIε ε ε ε ε ε ε ε ε ε= + + − − −                       (7) 
the equivalent strain, where Iε , IIε , IIIε  are the principal components of the strain tensor. This mechanical 
damage leads to a decrease of the bone stiffness, according with the relationship: 
0
1 ED
E
= −                                  (8) 
where E0 corresponds to the Young’s modulus of healthy bone and E is the actual value of Young’s modulus of 
the bone with cumulative mechanical damage. The κ  and γ  constants depend on the critical damage value, 
the critical strain and the deformation threshold, 0ε , below which no damage is produced ( cε  = 0ε  implies D 
= 0): 
0
1ln
1
ln
cri
cri
D
γ
ε
ε
 
 − =
 
 
 
         
( )0
1
γκ ε
=                          (9) 
where criε  corresponds to the equivalent strain value that produces the critical damage, Dcri. Once the damage 
model is defined, a relationship between the damage level and the probability of fracture must be set. Obviously 
several factors are involved in the equation and may difficult the calculations: damage location, amount of  
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(a) 
 
(b) 
 
(c) 
Figure 1. Fitting of BMD evolutionary curves: (a) Natural evolution (R2 = 
0.9942); (b) Risedronate (5 mg/day) (R2 = 0.995); (c) Denosumab (60 mg/6 
months) (R2 = 0.999).                                                
 
damage, range and type of load cycles, and so on. However, since osteoporosis is a generalized disease affecting 
bone mass extensively, and it occurs in older people with little variation in their life habits, a simplified model 
could be used. In this work, a model of fracture probability based on the law of Paris [50], which explains the 
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stable crack growth under monotonic loading, was developed. The number of loading cycles needed to increase 
damage from the Di value to the Df value was expressed as follows: 
( )
11 22
/2
1 1 1
1
2
i f
N
D D
ββ
β β β ω ωα σ γ
−−    = −           ∆ −    
                    (10) 
where α and β are material parameters associated with the law of Paris, γ  is a parameter related to the stress 
intensity factor defined in Linear Elastic Fracture Mechanics, which depends on geometric aspects and stress 
distribution, σ∆  is the variation of stress in each loading cycle and ω is a parameter which relates the me-
chanical damage to the crack size a (a = Dω ). 
By normalizing the probability of fracture, assigning value 1 to critical damage (D = Dcri), and value 0 to no 
damage (D = 0), we finally obtain a measure of the probability of fracture as a function of both the number of 
cycles and the damage: 
( )
1
2
max
( )1
cr
N D DP fracture
N D
β
−
 
= − =  
 í
                          (11) 
In Equation (11), the magnitude Nmax represents the maximum number of load cycles necessary for a me-
chanical damage equivalent to the critical value, Dcri. A value 5 has been given to the β coefficient for cortical 
bone, according to [51], and, in accordance with [49], a critical damage, Dcri, of 0.38 and a critical strain, criε , 
of 0.0174 have been considered, with a strain threshold, 0ε , of 0.0015 (no damage is produced by strains below 
0.0015). 
BMD evolutionary curves for a specific population are basic references and provide only general information. 
In order to apply the model to specific patients we must consider, in addition to the trend, the reference density 
value of the patient. According to the law of interpolated natural evolution, the density matching with the age of 
the patient is given by: 
( )0 0N tρ ρ≠                                    (12) 
being ( )0N tρ  the average density measured in the patient and 0ρ  the matching value from the reference pro-
gression curve, that is, the actual patient’s density doesn’t necessarily be equal to the value corresponding to the 
average curve for the considered population. There is an offset that should be added to the reference progression 
curve of density, providing a translation of the average curve, allowing an adaptation for each individual patient, 
so: 
( ) ( ) ( )0 0Np N Nt t tρ ρ ρ ρ = + −                              (13) 
when a drug therapy is applied to the same patient, a similar correction is required because a new offset appears. 
So, the progression curve for this patient under a treatment would be: 
( ) ( ) ( )0 0Tp T Tt t tρ ρ ρ ρ = + −                              (14) 
In the Equations (12) to (14), the subscripts or superscripts N and T represent natural evolution or evolution 
with treatment, respectively. All these adjustments provide the estimated BMD value for any type of patient, at 
any age, and under any prescribed therapy. From this value, mechanical properties of bone can be calculated. It 
must be noticed that the considered curves represent the mean evolutionary curves for the population, and an in-
dividual patient could not follow the curve exactly but in an approximate way. 
Densitometric data of the healthy lumbar spine have been taken as the starting point for this study, based on 
previous published works [47]. In that survey, densitometric data were correlated both with the apparent volu-
metric density, and with the Young moduli of each of the vertebral zones. Table 1 depicts the BMD, the appar-
ent volumetric density, and the Young moduli correlation corresponding to a healthy vertebra.  
From all the previous calculations, an evolutionary algorithm has been implemented (Figure 2), which has 
been used combined with a finite element model of the lumbar spine containing L4-L5-S1 segments (Figure 3), 
obtained from a previous complete model of the lumbar spine [52]. L4 and L5 vertebrae and S1 reproduce in a 
reliable way the anatomy of lumbar spine.  
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Table 1. BMD, apparent density and Young’s modulus for the data corresponding to the study of [48].                    
Zone Standard BMD (mg/cm2) Apparent volumetric density (gr/cm3) Young modulus (MPa) 
Vertebral wall 1159 1.494 9593 
Outer vertebral endplates 1159 1.494 9593 
Intermediate vertebral endplates 610 1.186 4797 
Centre of vertebral endplates 221 0.822 1599 
Apophyses 321 0.941 2398 
 
 
Figure 2. Evolutionary algorithm for the prediction of frac-
ture probability.                                     
 
The vertebrae were meshed by means of tetrahedral elements with quadratic approximation in the I-deas pro- 
gram [53] as described in [52]. The mesh of the discs is essential for the correct reproduction of the biome- 
chanical behaviour of the lumbar spine; in order to do this, each disc is divided into nucleus pulposus and annu- 
lus fibrosus with commonly accepted dimensions [54]. Each part is meshed separately, the nucleus by means of 
tetrahedra and the annulus by means of hexahedra and prisms with quadratic approximation. Later, nine layers 
(outer and four double crossed) of concentric fibres are added to the annulus. These layers are modelled by 
means of tension-only elements, included in the hexahedra matrix, with variable orientation from the most  
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(a)                         (b)                       (c) 
Figure 3. Complete FE model including vertebrae, discs and ligaments: (a) Frontal 
view; (b) Lateral view; (c) Dorsal view.                                         
 
internal to the most external (Figure 4), ranging from 35˚ to 80˚, respecting at most the anatomical disposition 
[55].  
Finally, the ligaments are modelled by means of tetrahedra and prisms with quadratic approximation; in addi-
tion, membrane elements have been used for capsular ligaments. The dimensions of those soft tissues corre-
spond to average anatomical measurements [54] [55] (Figure 3). The number of finite elements for every part is 
shown in Table 2. The total number of elements of the final mesh, obtained after a sensitivity analysis, is 
196,553. To this respect a mesh refinement was performed in order to achieve a convergence towards a mini-
mum of the potential energy, both for the whole model and for each of its components, with a tolerance of 1% 
between consecutive meshes. 
The bone and ligament properties were taken from the bibliography. Concerning the bone, in [56] it is dem-
onstrated that the centre of the vertebrae is less rigid than in the exterior zone. For this reason the vertebrae are 
divided into four areas with variable modulus of elasticity (Figure 5). In addition, the corresponding properties 
are used for the cancellous bone. Material properties are included in Table 2.  
The behaviour of the nucleus pulposus, like a non-compressible fluid, was simulated by means of the hypere-
lastic Mooney-Rivlin model (incompressible) incorporated in the Abaqus version 6.11 materials library [57]. 
The fibres of the annulus exhibit a non-linear only tension behaviour approximated using different linear models 
for each layer considering their respective range of deformation [56]. The materials of the matrix and cartilage 
of the apophyses were simulated as elastic materials. Finally, the different ligaments present non-linear only 
tension behaviour, included as a bilinear model in the strain range (Table 2) as with most of the reported FEM 
studies [56] [58]. 
As boundary conditions displacements in the wings of sacrum have been prevented. As load condition, a 
compression of 400 N was considered acting on the upper face of vertebra L4 (Figure 6). That compression 
simulates the load applied at the lumbar zone as consequence of body weight [59]. 
The model has been used in predicting the evolution of vertebral fracture probability, by comparing the natu-
ral history and the expected evolution under different therapies. 
3. Results 
Firstly, adjustment models were applied both to BMD physiological curve (weighted average from [47]) and the 
curves of patients under two different therapies: risedronate (5 mg per day) and denosumab (60 mg per 6 
months). Figure 1 shows the different evolutionary curves obtained in each case, together with the interpolated 
curves. Despite an extreme irregularity of some values, the correlation coefficients have been 0.994 (natural 
evolution), 0.995 and 0.997, respectively. 
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Figure 4. Model of the inter-vertebral disk and its layers of fibres.           
 
 
Figure 5. Zones of different elastic properties in the vertebral body.                      
 
   
(a)                                          (b) 
Figure 6. Boundary conditions: (a) Restrained displacements; (b) Load on L4.              
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Table 2. Statistics for the FE model and mechanical properties of materials, according with [52].                        
Material Young modulus (MPa) 
Poisson  
coefficient Element type 
Number of 
elements 
Outer vertebral endplates 12000 0.3 Tetrahedron 3578 
Intermediate vertebral endplates 6000 0.3 Tetrahedron 2244 
Centre of the vertebral endplates 2000 0.3 Tetrahedron 831 
Walls of the vertebral body 12000 0.3 Tetrahedron 37205 
Cancellous bone (inside vertebrae) 100 0.2 Tetrahedron 44954 
Posterior vertebra 3000 0.3 Tetrahedron 47134 
Cartilage 50 0.4 Wedge 3086 
Annulus fibrosus 4.2 0.45 Hexahedron 8288 
Nucleus pulposus (*) Incompressible material Tetrahedron 14410 
Annulus fiber layers 1 360 0.3 Truss (**) 592 
Annulus fiber layers 2 408 0.3 Truss (**) 592 
Annulus fiber layers 3 455 0.3 Truss (**) 592 
Annulus fiber layers 4 503 0.3 Truss (**) 592 
Annulus fiber layers 5 550 0.3 Truss (**) 296 
Ligament Young modulus (MPa) 
Transition strain 
(%) Element type 
Number of 
elements 
Anterior longitudinal ligament 7.8 20.0 12.0 Wedge (
**) 9046 
Posterior longitudinal ligament 10.0 50.0 11.0 Wedge (
**) 3844 
Ligamentum flavum 15.0 19.0 6.2 Tetrahedron (
**) 3042 
Intertransverse ligament 10.0 59.0 18.0 Tetrahedron (
**) 6678 
Capsular ligament 7.5 33.0 25.0 Membrane (
**) 3220 
Interspinous ligament 8.0 15.0 20.0 Tetrahedron (
**) 2856 
Supraspinous ligament 10.0 12.0 14.0 Tetrahedron (
**) 2657 
Iliolumbar ligament 7.8 20.0 12.0 Wedge (
**) 816 
(*) C01 = 0.0343 MPa; C10 = 0.1369 MPa. An elastic analysis with Young modulus of 1.0 MPa and Poisson ratio of 0.49 was carried out with similar 
results and a volume change less than 0.6%. (**) Only tension. 
 
Comparisons among various treatments can be drawn regarding different simulations. Figure 7(a) shows 
BMD evolution curves (average values) under natural conditions and under two therapies (risedronate and de-
nosumab). As can be seen, patients treated with desonumab showed a significant initial increase in bone density, 
which remained stable until the end of the study period. Risedronate also leads to a remarkable increase in BMD 
during the first 5 years; a progressive decline after treatment interruption appears (similar to the natural physio-
logical curve). In opposition, the physiological curve was characterized by a substantial and progressive decline 
in BMD linked to an increased risk of fracture. 
Equivalent comparisons can be made with different parameters. Thus, Figure 7(b) shows the evolution of av-
erage Young’s modulus in untreated patients and in those under drug therapy (risedronate and denosumab). 
Similar patterns to the observed in BMD curves were obtained, according with the direct relationship between 
the two parameters. Figure 7(c) shows the evolution of the average equivalent strain in subjects under natural 
conditions and under the same two therapies (risedronate and denosumab). Contrary to previous trends, as bone 
stiffness decreases the average deformation shows a significant increase (as it occurs in the natural history of 
BMD). In the case of therapies which preserve BMD, and therefore bone stiffness, the average strain value re-
mained stable or even decreases. Finally, Figure 7(d) illustrates the evolution of average mechanical damage 
under natural conditions and under the two proposed therapies (risedronate and denosumab). Similar trends to 
those obtained for strains can be seen. In fact, when the average strain value increases, mechanical damage in-
creases too. 
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As a final result, the evolutionary curves of fracture probability were obtained from the evolution of mechan-
ical damage. The estimated probability, according to mechanical damage caused by strains, is calculated for the 
initial patient’s state (Figure 7(e)). Evolutionary curves of fracture probability increase can be obtained by refe-
rencing all results to the initial state (Figure 7(f)). As can be seen, the fracture probability shows a marked in-
crease in the natural evolution curve, while the curves of the treated patients show lower degrees of risk, de-
pending on the therapy type. 
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(d) 
 
(e) 
 
(f) 
Figure 7. Evolution of different magnitudes at L5 vertebra: (a) BMD; (b) Av-
erage Young’s modulus; (c) Average equivalent strain; (d) Average mechanical 
damage; (e) Evolution of the average fracture probability at L5 in different con-
ditions; (f) Evolution of the average fracture probability increment at L5 in dif-
ferent conditions.                                                     
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In addition to previous results, programmed subroutines make it possible to obtain damage and fracture prob-
ability maps and to identify high-risk zones of the vertebral body (Figure 8(a) and Figure 8(b), respectively). 
Vertebral walls and external areas of vertebral end plates are the zones at greatest risk, in coincidence with the 
typical locations of osteoporotic fractures, characterized by a vertebral crushing due to the collapse of vertebral 
walls. It must be pointed out that Figure 8 doesn’t represent actual fracture zones, but zones with poorer bone 
mechanical strength due to cumulative damage. The actual fracture zone would be determined according loading 
scenario (fall, impact, accidental loads, etc.). 
4. Discussion 
The spinal localization of osteoporotic fractures is very common [3] [4] and unfortunately many of these frac-
tures are not diagnosed [7]-[10], so the availability of a tool to inform about of individualized fracture risk is 
important. It is essential to prevent the first fracture and therefore determine the risk of fracture is a most impor-
tant aid to the medical doctor for taking made decision to prescribe treatment. 
 
 
(a) 
 
(b) 
Figure 8. (a) Mechanical damage map for the studied patient ( 0ε  = 0.0015). Natural evolution 
(180 months); (b) Fracture probability increase (%) map for the studied patient ( 0ε  = 0.0015). 
Natural evolution (180 months).                                                     
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A novel method for estimating the risk in osteoporotic patients has been developed. Clinical data (DXA 
measures) and mechanical magnitudes related to bone strength were combined in this tool. The mechanical 
properties of bone are updated from BMD values obtained from clinical data of untreated patients and in those 
under different treatments. The model uses Damage and Fracture Mechanics concepts to evaluate the fracture 
probability in an evolutionary algorithm.  
The model can be used in a personalized way from BMD measurements in each case. The model can contri-
bute to the development of diagnostic tools for detection of early stages of osteoporosis. It may also be helpful 
for treatment decisions in selected patients. Many studies have been carried out, both in the clinical [9]-[19] and 
the simulation fields [20]-[30]. But a simple and reliable model, useful as a tool for diagnosis and prevention in 
our daily practice, has not yet been achieved. 
There are few studies in the bibliography, besides the tool FRAX®, to determine the risk of vertebral fracture. 
Some authors use clinical data to assess the risk of new fracture after the diagnosis of first vertebral fracture [10]. 
Other authors have employed logistic regression models based in clinical data and BMD of femoral neck to de-
termine the vertebral fracture risk [60]. Despite the data obtained by the quantitative computed tomography 
(QCT) were used to develop finite element models, the inconvenience of this technique is the much larger doses 
of radiation needed for QCT [61]. Other authors therefore employed human cadaveric specimens to obtain data 
by QCT under different loads to develop the prediction model [62] [63].  
Several predictive models can be found in the literature, but statistical models are currently the most reliable 
[9]-[12], regardless of mechanical issues involving bone strength estimated for different conditions and ages. 
The development of new techniques for measuring BMD has focused much of the recent research in the clinical 
setting, but the mechanical aspects have not been adequately studied [13]-[16]. In other cases, the improvements 
have been applied on statistical models previously [18] [19]. Only in one published paper [17] a new method de-
rived from DXA measures was developed for bone strength assessment. 
Concerning the finite element simulation, and based on previous micromechanical models [20], various me-
thods have been developed, but they are difficult to extrapolate to the scale required to get realistic predictions 
from different approaches [21] [22]. The incorporation of the latest imaging techniques (QCT) and BMD mea-
surement (DXA) [24] [27]-[29] has allowed the improvement of these models. However, most models use stan-
dard yield criteria for estimating the risk of fracture [27] [28], without considering essential aspects in fracture 
analysis. Nonetheless, all models assume that bone mineral density is the basic measurement, and it should 
therefore be used as a benchmark in predicting fracture risk.  
From the mechanical point of view, the exposition of the bone to cyclic loads of high value in a damaged 
bone, once the degenerative process is started, decreases its strength over the time and produces a cumulative 
damage which can lead to a final fracture. It seems apparent that Damage Mechanics and Fracture Mechanics 
criteria should be incorporated in any model intending to obtain reliable results. In this regard, our model com-
bines all these requirements, and might be useful as a basis for future more sophisticated models. 
Moreover, this model enables to incorporate future developments with the same methodology. In the first 
term, a more accurate bone density distribution by individual elements in the mesh could be used. That requires 
a planned collection of BMD data, by means of DXA or CT scan images. More complex damage models can be 
added, including mechanical behavior of anisotropic or mixed models, based on both deformations and tensions. 
It would also be possible to include crack growth models fitting to the results of in vitro bone fracture. Finally, a 
parametric finite element model of the femoral head could be performed including both the loads produced on 
the bone and the shape and dimensions of a specific patient. 
Despite DXA measurements just quantify bone mass and not bone quality, it is widely accepted as a macros-
copic indicator of bone strength and stiffness and also that micro-fractures exert an important influence on the 
mechanical strength of the bone. Finally, clinical trials are needed to validate the proposed model in order to ap-
ply it to the clinical practice helping for treatment decisions. 
5. Conclusion 
A mechanical model based on Damage and Fracture Mechanics and DXA measurements, for predicting the 
probability of fracture in osteoporotic patients has been carried out. The model represents a first step towards the 
development of new tools for diagnosis and prevention of osteoporosis. The incorporation of clinical measure-
ments and simulation results will be useful for an individualized monitoring and treatment in specific patients. 
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